Middle East and Africa In-Vitro Fertilization (IVF) Market Size- By Cycle Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Middle East and Africa In-Vitro Fertilization (IVF) Market Introduction and Overview

According to SPER market research, 'Middle East and Africa In-Vitro Fertilization (IVF) Market Size - By Cycle Type, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Middle East and Africa In-Vitro Fertilization (IVF) Market is predicted to reach USD 2956.17 million by 2033 with a CAGR of 11.99%.

In-Vitro Fertilization (IVF) is an intricate assisted reproduction procedure that provides infertile couples with hope. In order to fertilize a large number of eggs in a laboratory dish with sperm, the procedure entails stimulating a woman's ovaries to create an abundance of eggs. A few days after conception, the embryos are raised until one or more are chosen for implantation into the woman's uterus. IVF can make use of donated gametes or embryos, as well as the couple's own eggs and sperm.

The COVID-19 epidemic has had a major impact on the IVF markets in the Middle East and Africa, bringing with it both potential and challenges. In the early stages of the pandemic, government lockdowns and restrictions on non-essential medical treatments led several of the region's IVF facilities to close or reduce operations. This interruption to the patient's medication cycle resulted in many people experiencing uncertainty and delays in their reproductive journeys.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Cycle Type, By End User

Regions covered South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, Rest of the Middle and Africa

Companies Covered Aevitas Fertility Clinic, BIOART Fertility Clinic, Bloom IVF, CCRM Fertility, Gift ov life, Medic over.

Middle East and Africa In-Vitro Fertilization (IVF) Market Segmentation:

By Cycle Type: Based on the Cycle Type, Middle East and Africa In-Vitro Fertilization (IVF) Market is segmented as; Fresh IVF Cycles, Thawed IVF Cycles, Donor Egg IVF Cycles.

By End User: Based on the End User, Middle East and Africa In-Vitro Fertilization (IVF) Market is segmented as; Fertility Clinics, Hospitals, Surgical Centres and Clinical Research Institutes.

By Region: This research also includes data for South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, Rest of the Middle and Africa.

Product Code: HLCA2429

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Middle East and Africa In-Vitro Fertilization (IVF) Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Middle East and Africa In-Vitro Fertilization (IVF) Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Middle East and Africa In-Vitro Fertilization (IVF) Market

7. Middle East and Africa In-Vitro Fertilization (IVF) Market, By Cycle Type (USD Million)

7.1. Middle East and Africa In-Vitro Fertilization (IVF) Market Value Share and Forecast, By Cycle Type, 2024-2033
7.2. Fresh IVF Cycles
7.3. Thawed IVF Cycles
7.4. Donor Egg IVF Cycles

8. Middle East and Africa In-Vitro Fertilization (IVF) Market, By End User (USD Million)

8.1. Middle East and Africa In-Vitro Fertilization (IVF) Market Value Share and Forecast, By End User, 2024-2033
8.2. Fertility Clinics
8.3. Hospitals
8.4. Surgical Centres and Clinical Research Institutes

9. Middle East and Africa In-Vitro Fertilization (IVF) Market Forecast, 2020-2033 (USD Million)

9.1. Middle East and Africa In-Vitro Fertilization (IVF) Market Size and Market Share

10. Middle East and Africa In-Vitro Fertilization (IVF) Market, By Cycle Type, 2020-2033 (USD Million)

10.1. Middle East and Africa In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2020-2026)
10.2. Middle East and Africa In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2027-2033)

11. Middle East and Africa In-Vitro Fertilization (IVF) Market, By Region, 2020-2033 (USD Million)

11.1. Middle East and Africa In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2020-2026)
11.2. Middle East and Africa In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2027-2033)
11.3. South Africa
11.4. Saudi Arabia
11.5. UAE
11.6. Egypt
11.7. Kuwait
11.8. Israel
11.9. Rest of the Middle and Africa

12. Company Profile

12.1. Aevitas Fertility Clinic
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. BIOART Fertility Clinic
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Bloom IVF
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. CCRM Fertility.
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Gift ov life
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Medic over
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Others